OR WAIT 15 SECS
Introducing Applied Clinical Trials’ new enewsletter, CRO News, which provides a forum for the industry to discuss the latest alliances, financial information, and business deals and developments, as well as people news.
Premier Research Group and Octagon Research Solutions
Premier Research Group, a Philadelphia-based CRO, and Octagon Research Solutions a electronic solutions provider based in Wayne, PA, announced in late April the companies' formal intent to combine Octagon's electronic submissions capability with Premier's expertise across therapeutic areas. Each company will partner to offer the other's capabilities to its respective clients.
Clinsys Freshens Up Its Services
Within the span of two days, Clinsys Clinical Research announced two strategic moves. The Bedminster, NJ-based, therapeutically-focused CRO introduced its Therapeutically-aligned Program Strategists. These teams consist of MDs, PhDs, and a clinical operations program director with expertise in a specific therapeutic area. Its second announcement was the launch of Clinsys ALTERNA, billed on its Web site as providing customized Phase I through IV clinical trial alternative solutions.
>> MORE (TPS) >> MORE (ALTERNA)
CRO Goes Green
At ProTrials, the environment is an important issue, and one that employees support. Read more about how the Mountain View, CA-based CRO initiates green policies in this interview with co-founder and president Inger Arum.
Axiom Accelerated Patient Recruitment
Partner with Axiom Accelerated Patient Recruitment to develop customized recruitment initiatives that motivate qualified patients. Leave Patient Recruitment To The Experts. Visit:
PERI's Global Regulatory Affairs: Overview of Drugs & Biologics
May 19–21, 2008
Location | Washington, DC
SMi's Clinical Trials Logistics
May 21–22 , 2008
Location | London, UK
DIA's 2nd Annual Conference for Asian New Drug Development
May 29–30 , 2008
Location | Tokyo, Japan
|>>||Go to Applied Clinical Trials Web site|
"A Quick Guide to Clinical Trials" was recently unveiled. The book was edited by Dr. Madhu Davies and Dr. Faiz Kermani. Click here for a review of the book.
Check out the CRO + EDC Special Report from ClinPage for insights into this group dynamic. Part III is here.
We're looking forward to the outcomes from the Post-Approval Summit being held at Harvard Medical School today and tomorrow. Link here to read the high-powered agenda at the Summit's site.
Increasingly complex protocol design is negatively impacting clinical trials, and a new study confirms it. Read Ken Getz's column about it here.
You are subscribed to %%list.name%% as %%emailaddr%%. To unsubscribe from this list click here.
To ensure delivery to your Inbox, please add %%email.list%% to your address book. If you need help doing this, click here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.